| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0004 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0009 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |